Activity
Lab Retreat
Great to see 12 young people discussing and elaborating new ideas. After an exciting winter hike we spend 3 days of brainstorming and learning from each other – truly inspiring + great new ideas
Awards
Poster Award
David Pereyra received the best poster award at this years 11th EFR (european federation for colorectal cancer) congress with our work on Osteopontin and its association with disease recurrence after liver resection. TELLvienna congratulates to this great achievement! Great performance and well deserved!
Research
ILC/EASL Updates for HB surgeons
ILC/EASL 2019 Excited to see major interest in our work @ILC2019, EASL in Vienna. Thank you @Medizin Medien Austria for featuring our results and surgical highlights of the congress with an interview – great pleasure. https://medonline.at/innere-medizin/onkologie/krebshilfe/easl-ilc/2019/10028197/easl-ilc-2019-leber-aus-dem-labor-und-weitere-highlights-fuer-chirurgen/
Research
ASO -Author Reflection
Ever found it puzzling that a patient with more than 12 months of neoadjuvant chemotherapy flies trough postoperative recovery after major liver resection without any signs of chemotherapy associated steatohepatitis (CASH) on histology, while some patients after only 2 months of systemic therapy struggle significantly due to chemotherapy associated liver Read more…
Research
Micro RNAs in HB surgery
Remember your last patient developing liver failure after liver resection? Proofs of our recent work on miRNAs in liver surgery are out now demonstrating that miRNAs are sensitive markers for preoperative liver function and predict postoperative outcomes – freely available on: https://lnkd.in/dUq25YG A major step towards personalized medicine in HB Read more…
Research
Non-invasive CASH assessment
Ever found it puzzling that a patient with more than 12 months of neoadjuvant chemotherapy flies trough postoperative recovery after major liver resection without any signs of chemotherapy associated steatohepatitis (CASH) on histology, while some patients after only 2 months of systemic therapy struggle significantly due to chemotherapy associated liver Read more…